Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.F Hoffmann-La Roche (Roche) has agreed to jointly develop health research technologies in collaboration with the Centre for Drug Research and Development's (CDRD) commercial arm, CDRD Ventures (CVI).
Subscribe to our email newsletter
As per the terms of the deal, CDRD Ventures will drive the development of projects together with Roche.
The agreement allows CVI to support Canadian health researchers for developing novel therapeutics targeting the diseases with high unmet medical need.
CDRD president and CEO Natalie Dakers said this will allow them to address the commercialization gap between academia and the private sector, and in doing so, bring new therapeutics to the patients who need them.